Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: A natural history study

Drug and Alcohol Dependence

Volumn 160, Issue , 2016, Pages 127-134

  Carlson, Robert G ^a   Nahhas, Ramzi W ^a   Martins, Silvia S ^b   Daniulaityte, Raminta ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b Department of Medicine   (United States)

Author keywords

Heroin initiation; Illicit pharmaceutical opioid use; Natural history study; Opioid dependence; Time to event analysis

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; ATTRIBUTABLE RISK; CAUCASIAN; CONTROLLED STUDY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HEALTH HAZARD; HEROIN DEPENDENCE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OPIATE ADDICTION; OUTCOME ASSESSMENT; POPULATION RISK; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF MEDICATION; SEX DIFFERENCE; AGE; CROSS-SECTIONAL STUDY; OHIO; PRESCRIPTION DRUG MISUSE; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGY; QUESTIONNAIRE; RETROSPECTIVE STUDY; TIME FACTOR; YOUNG ADULT;

DIAMORPHINE;

ADULT; AGE FACTORS; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEROIN; HEROIN DEPENDENCE; HUMANS; MALE; OHIO; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG MISUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; YOUNG ADULT;

EID: 84960094206     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.12.026     Document Type: Article

References (71)

1. Adair E.B.G., Craddock S.G., Miller H.G., Turner C.F. Assessing consistency of responses to questions on cocaine use. Addiction 1995, 90:1497-1502.
2. Arnett J.J. Emerging adulthood: a theory of development from the late teens through the twenties. Am. Psychol. 2000, 55:469-480.
3. Bachman J.G., Johnston L.D., O'Malley P.M., Schulenberg J.E. Transitions in drug use during late adolescence and young adulthood. Transitions Through Adolescence: Interpersonal Domains and Context 1996, 111-140. Erlbaum Mahwah, NJ. J.A. Graber, J. Brooks-Gunn, A.C. Petersen (Eds.).
4. Carlson R.G., Wang J., Falck R.S., Siegal H.A. Drug use practices among mdma/ecstasy users in Ohio: a latent class analysis. Drug Alcohol Depend. 2005, 79:167-179.
5. Carlson R.G., Nahhas R.W., Daniulaityte R., Martins S.S., Li L., Falck R. Latent class analysis of non-opioid dependent illegal pharmaceutical opioid users in Ohio. Drug Alcohol Depend. 2014, 134:259-266.
6. Caviness L.L., Cunningham D.B., Gibson L. National Survey on Drug Use and Health 2006, RTI International, Research Triangle Park, NC.
7. Cerdá M., Santaella J., Marshall B.D.L., Kim J.H., Martins S.S. Nonmedical prescription opioid use in childhood and early adolescence predicts transition to heroin use in young adulthood: a national study. J. Pediatr. 2015, 167:605-612.
8. Cicero T.J., Ellis M.S., Surratt H.L., Kurtz S.P. The changing face of heroin use in the United States a retrospective analysis of the past 50 years. JAMA Psychiatry 2014, 71:821-826.
9. Cicero T.J., Ellis M.S. Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: lessons learned from OxyContin. JAMA Psychiatry 2015, 72:424-430.
10. Cox D.R. Regression models and life-tables. J. R. Stat. Soc. Ser. B Methodol. 1972, 34:187-220.
11. Daniulaityte R., Carlson R.G., Kenne D.R. Initiation to pharmaceutical opioids and patterns of misuse: preliminary qualitative findings obtained by the Ohio substance abuse monitoring network. J. Drug Issues 2006, 36:787-808.
12. Daniulaityte R., Falck R., Li L., Nahhas R.W., Carlson R.G. Respondent-driven sampling to recruit young adult non-medical users of pharmaceutical opioids: problems and solutions. Drug Alcohol Depend. 2012, 121:23-29.
13. Daniulaityte R., Falck R., Carlson R.G. Sources of pharmaceutical opioids for non-medical use among young adults. J. Psychoact. Drugs 2014, 46:198-207.
14. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998, 51:253-263.
15. Dasgupta N., Creppage K., Austin A., Ringwalt C., Sanford C., Proescholdbell S.K. Observed transition from opioid analgesic deaths toward heroin. Drug Alcohol Depend. 2014, 145:238-241.
16. Falck R.S., Siegal H.A., Wang J., Carlson R.G., Draus P.J. Non-medical drug use among adults in small towns in rural Ohio. J. Subst. Abuse Treat. 2005, 28:341-349.
17. Forman R.F., Svikis D., Montoya I.D., Blaine J. Selection of a substance use disorder diagnostic instrument by the national drug abuse treatment clinical trials network. J. Subst. Abuse Treat. 2004, 27:1-8.
18. Gile K.J., Handcock M.S. Respondent-driven sampling: an assessment of current methodology. Sociol. Methodol. 2010, 40:285-327.
19. Goel S., Salganik M.J. Assessing respondent-driven sampling. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:6743-6747.
20. Gossop M., Griffiths P., Powis B., Strang J. Cocaine: patterns of use, route of administration, and severity of dependence. Br. J. Psychiatr. 1994, 164:660-664.
21. Hays L.R. A profile of oxycontin addiction. J. Addict. Dis. 2004, 23:1-9.
22. Heckathorn D.D. Respondent-driven sampling: a new approach to the study of hidden population. Soc. Prob. 1997, 44:174-199.
23. Heckathorn D.D. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc. Prob. 2002, 49:11-34.
24. Hingson R.W., Heeren T., Winter M.R. Age at drinking onset and alcohol dependence. Arch. Prediatr. Adolesc. Med. 2006, 160:739-746.
25. Hudziak J.J., Helzer J.E., Wetzel M.W., Kessel K.B., McGee B., Janca A., Przybeck T. The use of the DSM-III R checklist for initial diagnostic assessments. Compr. Psychiatry 1993, 34:375-383.
26. Johnston L.G. Behavioural Surveillance: Introduction to Respondent Driven Sampling (Participant Manual) 2008, Centers for Disease Control and Prevention, Atlanta, GA.
27. Johnston L.G., Malekinejad M., Kendall C., Iuppa I.M., Rutherford G.W. Implementation challenges to using respondent-driven sampling methodology for HIV biological and behavioral surveillance: field experiences in international settings. AIDS Behav. 2008, 12:S131-S141.
28. Johnston L.G., Sabin K. Sampling hard-to-reach populations with respondent-driven sampling. Methodol. Innov. 2010, 5:38-48.
29. Johnston L.D., O'Malley P.M., Bachman J.G., Schulenberg J.E. Volume I: secondary school students. Monitor ing the Future National Survey Results on Drug use, 1975-2009 2010, National Institute on Drug Abuse Bethesda, MD.
30. Jones C.M. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers-United States, 2002-2004 and 2008-2010. Drug Alcohol Depend. 2013, 132:95-100.
31. Jones C.M., Logan J., Gladden R.M., Bohn M.K. Vital signs: demographic and substance use trends among heroin users-United States, 2002-2013. MMWR 2015, 64:719-727.
32. Kandel D., Yamaguchi K. From beer to crack: developmental patterns of drug involvement. Am. J. Public Health 1993, 83:851-855.
33. Kirsh K., Peppin J., Coleman J. Characterization of prescription opioid abuse in the United States: focus on route of administration. J. Pain Palliat. Care Pharmacother. 2012, 26:348-361.
34. Lankenau S.E., Teti M., Silva K., Bloom J.J., Harocopos A., Treese M. Initiation into prescription opioid misuse amongst young injection drug users. Int. J. Drug Policy 2012, 23:37-44.
35. Lee D., Delcher C., Maldonado-Molina M.M., Bazydlo L.A., Thogmartin J.R., Goldberger B.A. Trends in licit and illicit drug-related deaths in Florida from 2001 to 2012. Forensic Sci. Int. 2014, 245C:178-186.
36. Li G., Lu H., Li X., Sun Y., He X., Fan S., McFarland W., Jia Y., Raymond H.F., Xiao Y., Ruan Y., Shao Y. Mutual HIV disclosure among HIV-negative men who have sex with men in Beijing, China, 2010. Arch. Sex Behav. 2012, 42:1267-1273.
37. Mars S.G., Bourgois P., Karandinos G., Montero F., Ciccarone D. Every 'never' I ever said came true: transitions from opioid pills to heroin injecting. Int. J. Drug Policy 2014, 25:257-266.
38. Martins S.S., Santaella-Tenorio J., Marshall B.D., Maldonado A., Cerda M. Racial/ethnic differences in trends in heroin use and heroin-related risk behaviors among nonmedical prescription opioid users. Drug Alcohol Depend. 2015, 151:278-283.
39. Martins S.S., Storr C.L., Zhu H., Chilcoat H.D. Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population. Drug Alcohol Depend. 2009, 99:58-67.
40. Massatti R., Beeghly C., Hall O., Kariisa M., Potts L. Increasing Heroin Overdoses in Ohio: Understanding the Issue 2014, Ohio Department of Mental Health and Addiction Services, Columbus, OH.
41. McCabe S.E., Cranford J.A., Boyd C.J., Teter C.J. Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addict. Behav. 2007, 32:562-575.
42. McCabe S.E., West B.T., Morales M., Cranford J.A., Boyd C.J. Does early age of onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction 2007, 102:1920-1930.
43. McCabe S.E., Cranford J.A., West B.T. Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. Addict. Behav. 2008, 33:1297-1305.
44. McCabe S.E., Boyd C.J., Teter C.J. Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend. 2009, 102:63-70.
45. McCabe S.E., West B.T., Boyd C.J. Motives for medical misuse of prescription opioids among adolescents. J. Pain 2013, 14:1208-1216.
46. Muhuri P.K., Gfroerer J.C., Davies M.C. CBHSQ data review: center for behavioral health statistics and quality. Associations of Nonmedical Pain Reliever Use and Initiation of Heroin use in the United States 2013, 1-17. SAMHSA.
47. Natarajan S., Lipsitz S.R., Rimm E. A simple method of determining confidence intervals for population attributable risk from complex surveys. Stat. Med. 2007, 26:3229-3239.
48. Ohio Department of Health, 2014. 2014 Ohio drug overdose preliminary data: general findings. http://www.healthy.ohio.gov/vipp/drug/dpoison.aspx. Accessed 9.15.15.
49. OpenEpi, OpenEpi version 2.3.1, 2010 Accessed November 30 2010; 2015 http://saber.salud.gob.sv/openepi/Menu/OpenEpiMenu.htm.
50. Passik S.D., Hays L., Eisner N., Kirsh K.L. Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation. J. Pain Palliat. Care Pharmacother. 2006, 20:5-13.
51. Paulozzi L.J., Budnitz D.S., Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol. Drug Saf. 2006, 15:618-627.
52. Peavy K.M., Banta-Green C., Kingston S., Hanrahan M., Merrill J.O., Coffin P.O. Hooked on prescription-type opiates prior to using heroin: results from a survey of syringe exchange clients. J. Psychoact. Drugs 2012, 44:259-265.
53. Pollini R.A., Banta-Green C.J., Metzner M., Teshale E., Garfein R.S. Problematic use of prescription opioids prior to heroin use among young heroin injectors. Subst. Abuse Rehabil. 2011, 2:173-180.
54. Robins L., Cottler L., Bucholz K., Compton W. National Institute of Mental Health Diagnostic Interview Schedule for DSM-IV 1999, Washington University Department of Psychiatry, St. Louis, MO.
55. Rudd R.A., Paulozzi L.J., Bauer M.J., Burleson R.W., Carlson R.E., Dao D., Davis J.W., Dudek J., Eichler B.A., Fernandes J.C., Fondario A., Gabella B., Hume B., Huntamer T., Kariisa M., Largo T.W., Miles J., Newmyer A., Nitcheva D., Perez B.E., Proescholdbell S.K., Sabel J.C., Skiba J., Slavova S., Stone K., Tharp J.M., Wendling T., Wright D., Zehner A.M. Increases in heroin overdose deaths - 28 States, 2010 to 2012. Centers for Disease Control and Prevention (CDC) 2014, 849-854. MMWR.
56. Samaha A.N., Robinson T.E. Why does the rapid delivery of drugs to the brain promote addiction?. Trends Pharmacol. Sci. 2005, 26:82-87.
57. SAS Institute Inc SAS Version 9.3 2010, SAS Institute Inc., Cary, NC.
58. Siegal H.A., Carlson R.G., Kenne D.R., Swora M.G. Probable relationship between opioid abuse and heroin use. Am. Fam. Physician 2003, 67(942):945.
59. Siegal H.A., Carlson R.G., Kenne D.R., Swora M.G. Probable relationship between opioid abuse and heroin use. Am. Fam. Physician 2003, 67(942):945.
60. Siegal H.A., Falck R.S., Carlson R.G., Wang J., Rahman A.M. Health services research among crack-cocaine users: a case study from the midwest. Am. Behav. Sci. 1998, 41:1063-1078.
61. Strang J., Des Jarlais D.C., Griffiths P., Gossop M. The study of transitions in the route of drug use: the route from one route to another. Br. J. Addict. 1992, 87:473-483.
62. Strang J., Bearn J., Farrell M., Finch E., Gossop M., Griffiths P., Marsden J., Wolff K. Route of drug use and its implications for drug effect, risk of dependence and health consequences. Drug Alcohol Rev. 1998, 7:197-211.
63. Substance Abuse and Mental Health Services Administration (SAMHSA) Results from the 2009 National Survey on Drug use and Health: Detailed Tables 2010, Office of Applied Studies, Rockville, MD.
64. Ternes J.W., O'Brien C.P. The opioids: abuse liability and treatments for dependence. Adv. Alcohol Subst. Abuse 1990, 9:27-45.
65. Unick G.J., Rosenblum D., Mars S., Ciccarone D. Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009. PLoS One 2013, 8:e54496.
66. United States Census Bureau, 2010 American Fact Finder http://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=CF. Accessed September 15 2015.
67. Wang J., Carlson R.G., Falck R.S., Siegal H.A., Rahman A., Li L. Respondent-driven sampling to recruit MDMA users: a methodological assessment. Drug Alcohol Depend. 2005, 78:147-157.
68. Wang J., Falck R.S., Li L., Rahman A., Carlson R.G. Respondent-driven sampling in the recruitment of illicit stimulant drug users in a rural setting: findings and technical issues. Addict. Behav. 2007, 32:924-937.
69. Yan H., Yang H., Zhao J., Wei C., Li Jianjun Huan X., Raymond H.F., McFarland W. Long-chain peer referral of men who have sex with men: a novel approach to establish and maintain a cohort to measure HIV incidence, Nanjing, China. J. Acquir. Immune Defic. Syndr. 2012, 59:177-184.
70. Young A.M., Havens J.R., Leukefeld C.G. Route of administration for illicit prescription opioids: a comparison of rural and urban drug users. Harm Reduct. J. 2010, 7:24.
71. Young A.M., Havens J.R. Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis. Addiction 2011, 107:587-596.